Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
PLoS One. 2021 Oct 27;16(10):e0258935. doi: 10.1371/journal.pone.0258935. eCollection 2021.
Retraction of published research can reduce the dissemination of incorrect or misleading information, but concerns have been raised about the clarity and rigor of the retraction process. Failure to clearly and consistently retract research has several risks, for example discredited or erroneous research may inform health research studies (e.g. clinical trials), policies and practices, potentially rendering these unreliable.
To investigate consistency and clarity of research retraction, based on a case study of retracted Covid-19 research.
A cross-sectional study of retracted Covid-19 articles reporting empirical research findings, based on searches of Medline, Embase and Scopus on 10th July and 19th December 2020.
We included 46 retracted Covid-19 articles. The number eligible for inclusion nearly doubled, from 26 to 46, in five months. Most articles (67%) were retracted from scientific journals and the remainder from preprint servers. Key findings: (1) reasons for retraction were not reported in 33% (15/46) of cases; (2) time from publication to retraction could not be determined in 43% (20/46) of cases; (3) More than half (59%) of retracted Covid-19 articles (27/46) remained available as original unmarked electronic documents after retraction (33% as full text and 26% as an abstract only). Sources of articles post-retraction were preprint servers, ResearchGate and, less commonly, websites including PubMed Central and the World Health Organization. A retracted journal article which controversially claimed a link between 5G technology and Covid-19 remains available in its original full text from at least 60 different websites.
The retraction process is inconsistent and often ambiguous, with more than half of retracted Covid-19 research articles remaining available, unmarked, from a wide range of online sources. There is an urgent need to improve guidance on the retraction process and to extend this to cover preprint servers. We provide structured recommendations to address these concerns and to reduce the risks that arise when retracted research is inappropriately cited.
撤回已发表的研究可以减少错误或误导性信息的传播,但人们对撤回过程的清晰度和严谨性提出了担忧。未能明确一致地撤回研究有几个风险,例如,声誉受损或错误的研究可能会影响健康研究(例如临床试验)、政策和实践,从而使这些研究变得不可靠。
以撤回的新冠病毒研究案例为基础,调查研究撤回的一致性和清晰度。
这是一项基于 Medline、Embase 和 Scopus 在 2020 年 7 月 10 日和 12 月 19 日检索的关于撤回的新冠病毒研究报告经验性研究结果的撤回研究的横断面研究。
我们纳入了 46 篇撤回的新冠病毒文章。在五个月内,符合纳入标准的文章数量几乎翻了一番,从 26 篇增加到 46 篇。大多数文章(67%)是从科学期刊撤回的,其余的是从预印本服务器撤回的。主要发现:(1)46 篇病例中有 33%(15/46)未报告撤回原因;(2)46 篇病例中有 43%(20/46)无法确定发表到撤回的时间;(3)一半以上(59%)的撤回的新冠病毒文章(27/46)在撤回后仍然作为原始未标记的电子文件可用(33%为全文,26%仅为摘要)。撤回后文章的来源包括预印本服务器、ResearchGate 以及较少见的 PubMed Central 和世界卫生组织网站。一篇有争议地声称 5G 技术与新冠病毒之间存在联系的撤回期刊文章仍然可以从至少 60 个不同的网站获得其原始全文。
撤回过程不一致且常常模糊不清,超过一半的撤回的新冠病毒研究文章仍然可以从广泛的在线来源中以未标记的形式获得。迫切需要改进撤回过程的指导,并将其扩展到预印本服务器。我们提供了结构化的建议来解决这些问题,并减少不当引用撤回研究带来的风险。